MMMichal A. Mankowski

Michal A. Mankowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michal A. Mankowski has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hybrid Kidney Allocation: Improving Equity by Fair Integration of Deceased Donor-Initiated Chains in Kidney Exchange

    by Roby Cremers, Twan Dollevoet, Joris van de Klundert, Michal Andrzej A. Mankowski

    Problem definition: Living donor kidney exchange programs (KEPs) expand access to transplants by enabling exchanges among patient-donor pairs. However, highly sensitized patients are disproportionately hard to match and face long waits. Deceased donor–initiated chains (DDICs) have been proposed to enable more transplants by diverting an occasional deceased donor kidney from the waitlist to start a KEP chain, which ends by returning a kidney to the waitlist. Yet, DDICs have seen virtually no implementation. In the U.S., this is largely due to concerns that the kidneys returned may differ in blood-type distribution from those diverted, disadvantaging waitlist patients of certain blood types. We study how DDICs can be integrated into KEPs while explicitly protecting blood-type-specific waitlist access. Methodology/results: We develop two forward-looking optimization approaches: one that solves a stochastic model using Sample Average Approximation (SAA) and one that solves a static model with forward-looking constraints. Through simulation, we show that forward-looking models are needed to preserve the blood-type distribution of donations to the waitlist. Under both models, even limited use of DDICs significantly increases transplant rates for highly sensitized patients. While the static approach requires only modest extensions to models as currently used in practice, the more complex and time consuming SAA-based approach yields larger equity gains. Managerial implications: DDICs can improve access to life-saving transplants for the most disadvantaged KEP patients without reducing access for any blood type on the waitlist. By explicitly controlling the blood-type distribution of waitlist donations, matching policies can address objections that have hindered DDIC adoption, calling for renewed policy evaluation.

  • Center geography or center practice? Decomposing geographic variation in access to deceased donor liver transplantation

    by Tanveen Ishaque, Luckmini Liyanage, Luis Arias-Espinosa, Michal A. Mankowski, Karim J. Halazun, Dorry L. Segev, Sommer E. Gentry, Allan B. Massie, Darren E. Stewart

  • Evaluating Barriers to Kidney Transplantation in the United States

    by Conor B. Donnelly, Suhani S. Patel, Syed Ali Husain, Sommer E. Gentry, Rachel E. Patzer, Bonnie E. Lonze, Sunjae Bae, David Axelrod, Babak J. Orandi, Mara A. McAdams-DeMarco, et al.

    Key Points: In this cohort study of 720,348 adults referred for kidney transplantation from 2014 to 2025, only 48% were evaluated and 19% were waitlisted. Progression from referral to evaluation, waitlisting and kidney transplantation was limited by individual, center-level, and geographic factors. Some centers evaluated and waitlisted patients at rates far below the national average, and low-volume centers had lower rates of transplantation. Background: Kidney transplantation is a cost-effective, lifesaving treatment of kidney failure, compared with dialysis. Unfortunately, most patients with kidney failure never undergo transplantation. Methods: Using Epic Cosmos electronic health record data on all patients referred for kidney transplantation from 2014 to 2025, we assessed the stage-specific progression and attrition in the process of evaluation, waitlisting, and kidney transplantation. Center-level and individual (socioeconomic, geographic, and insurance status) factors associated with access to evaluation, waitlisting, and kidney transplantation were characterized using modified Poisson regression. Results: Among 720,348 referred candidates, the median age was 55 years (interquartile range [IQR], 42–64); 47% of patients were White, 52% were male, and 87% were English speaking. Eighty-five percent of patients lived in urban areas. Of the referred candidates, 48% initiated evaluation, 19% were waitlisted, and 10% ultimately underwent transplantation. Among the referred patients who initiated evaluation, the median (IQR) time to evaluation initiation was two (1–4) months after referral; among the patients who were waitlisted, the median (IQR) time to waitlisting was four (2–9) months after evaluation initiation. Patients who were never married (0.94; 95% confidence interval [CI], 0.93 to 0.94), had severe obesity (0.70; 95% CI, 0.69 to 0.72), or were from rural zip codes (relative risk, 0.98; 95% CI, 0.97 to 1.00) were less likely to initiate evaluation. Low-volume centers had lower relative rates of transplantation (0.92; 95% CI, 0.88 to 0.96). In centers with documentation for nonprogression to evaluation, reasons for removal included not meeting criteria/not a candidate (18%), patient decision (13%), unable to contact (12%), death (4%), and financial/insurance complications (7%). Conclusions: Our study shows substantial attrition before kidney transplant waitlisting.


  • Center Geography or Center Practice? Decomposing Geographic Variation in Access to Kidney Transplantation Before Versus After Circles

    by Luckmini N. Liyanage, Darren E. Stewart, Tanveen Ishaque, Dorry L. Segev, Michal A. Mankowski, Allan B. Massie, Sommer E. Gentry

    Background: Before KAS250 (circles‐based allocation), donor service area (DSA) of listing was the largest contributor to deceased donor kidney transplantation (DDKT) rate disparities. Both before and after KAS250, it is unclear to what extent DSA‐level disparities are attributable to center‐level practice variation. We aimed to disentangle contributions to DDKT rate variation from: (1) center practices, (2) kidney distribution within sharp policy boundaries (DSAs, OPTN Regions), and (3) other geographic variation in kidney scarcity. Methods: With national transplant registry data, we studied transplant rate variation in the pre‐KAS250 era, which prioritized patients based on DSAs and Regions, and under KAS250, which prioritizes patients within 250 nautical mile circles. We modeled candidate DDKT rates with multilevel Poisson regression, adjusting for candidate factors, and calculated median incidence rate ratios (MIRR) to summarize variation attributable to DSAs, OPTN regions, states, census divisions, and to centers within those units. Results: DSA‐level MIRR declined sharply from 1.31 1.35 1.39 to 1.13 1.17 1.21 after KAS250 implementation. Under KAS250, 93.4% of geographic variability in transplant rates was attributable to center‐level (within‐DSA) variation (MIRR: centers 1.76 1.82 1.86 , DSAs 1.13 1.17 1.21 ), while before KAS250, only 81.7% of geographic variability in transplant rates was attributable to center‐level (within‐DSA) variation (MIRR: centers 1.83 1.89 1.95 , DSAs 1.31 1.35 1.39 ). Adjusted center‐level DDKT rates under KAS250 were highly associated with offer acceptance rates ( ρ = 0.60, p < 0.001). Conclusions: Though geographic disparities are driven primarily by center‐level practice differences including offer acceptance, KAS250 did reduce DSA‐level disparities. Further allocation policy changes are unlikely to substantially reduce geographic variation in DDKT rates.


  • Open Access

    A Multi-AI Agent Framework for Interactive Neurosurgical Education and Evaluation: From Vignettes to Virtual Conversations

    by Karl L. Sangwon, Jeff Zhang, Robert Steele, Jaden Stryker, Joanne J. Choi, Jin Vivian Lee, Daniel Alexander Alber, Aly Valliani, Nivedha Kannapadi, James Ryoo, et al.

    BACKGROUND AND OBJECTIVES: Traditional medical board examinations present clinical information in static vignettes with multiple-choices (MC), fundamentally different from how physicians gather and integrate data in practice. Recent advances in large language models (LLMs) offer promising approaches to creating more realistic clinical interactive conversations. However, these approaches are limited in neurosurgery, where patient communication capacity varies significantly and diagnosis heavily relies on objective data such as imaging and neurological examinations. We aimed to develop and evaluate a multi–artificial intelligence (AI) agent conversation framework for neurosurgical case assessment that enables realistic clinical interactions through simulated patients and structured access to objective clinical data. METHODS: We developed a framework to convert 608 Self-Assessment in Neurological Surgery first-order diagnosis questions into conversation sessions using 3 specialized AI agents: patient AI for subjective information, system AI for objective data, and clinical AI for diagnostic reasoning. We evaluated generative pretrained transformer 4o's (GPT-4o's) diagnostic accuracy across traditional vignettes, patient-only conversations, and patient + system AI interactions, with human benchmark testing from 10 neurosurgery residents. RESULTS: GPT-4o showed significant performance drops from traditional vignettes to conversational formats in both MC (89.0%-60.9%, P < .0001) and free-response scenarios (78.4%-30.3%, P < .0001). Adding access to objective data through system AI improved performance (to 67.4%, P = .0015; and 61.8%, P < .0001, respectively). Questions requiring image interpretation showed similar patterns but lower accuracy. Residents outperformed GPT-4o in free-response conversations (70.0% vs 28.3%, P = .0030) using fewer interactions and reported high educational value of the interactive format. CONCLUSION: This multi-AI agent framework provides both a more challenging evaluation method for LLMs and an engaging educational tool for neurosurgical training. The significant performance drops in conversational formats suggest that traditional MC testing may overestimate LLMs' clinical reasoning capabilities, while the framework's interactive nature offers promising applications for enhancing medical education.


  • Evaluating the representativeness and validity of Cosmos as a novel, large-scale, real-world data source for liver transplant research

    by Alexandra T. Strauss, Kelly Terlizzi, Babak Orandi, Darren Stewart, Allan B. Massie, Tyrus Vong, Vedant S. Jain, Valerie L. Thompson, Mara A. McAdams DeMarco, Eduardo Iturrate, et al.

    Liver transplant (LT) recipients experience a wide range of comorbidities, leading to frequent healthcare encounters. Until now, national registries, which have limited exposures and outcomes, and laborious small cohort studies have been the main data sources for LT research. Cosmos database offers electronic health record (EHR)-based insights into LT recipients at the national level with granular data. We evaluated whether Cosmos data is representative of the entire US LT recipient population. Using Cosmos (N=20,235) and the national Scientific Registry of Transplant Recipients (SRTR) (N=51,281), we identified adult, first-time LT recipients between July 2016 and December 2022. We compared demographics, clinical data, and mortality across datasets, calculating Kaplan–Meier survival estimates and multivariable Cox regressions. Recipient characteristics were highly comparable (eg, female: Cosmos=36.5% vs. SRTR=36.4%, Black: 6.8% vs. 7.2%; BMI: 28.5 kg/m 2 [24.8–32.9] vs. 28.2 [24.6–32.4]). Lab values were similar across cohorts, including MELD (24 [17–30] vs. 23 [16–30]). Transplant indications, donor characteristics, and 5-year survival (Cosmos 83.1% [82.3–83.8] vs. SRTR 80.9% [80.4–81.3]) were similar. The associations of clinical factors with survival were similar across both groups. The Cosmos database demonstrated acceptable generalizability to the general US LT recipient population, which may advance LT research through a better understanding of LT recipients’ experiences and outcomes.


  • Open Access

    Balancing equity and human leukocyte antigen matching in deceased-donor kidney allocation with eplet mismatch

    by Michal A. Mankowski, Loren Gragert, Brendan Keating, Bonnie E. Lonze, Dorry L. Segev, Robert Montgomery, Sommer E. Gentry, Massimo Mangiola


  • Open Access

    Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients

    by Michal A. Mankowski, Sunjae Bae, Alexandra T. Strauss, Bonnie E. Lonze, Babak J. Orandi, Darren Stewart, Allan B. Massie, Mara A. McAdams-DeMarco, Eric K. Oermann, Marlena Habal, et al.


  • Hospitalization and Hospitalized Delirium Are Associated With Decreased Access to Kidney Transplantation and Increased Risk of Waitlist Mortality

    by Jane J. Long, Jingyao Hong, Yi Liu, Akanksha Nalatwad, Yiting Li, Nidhi Ghildayal, Emily A. Johnston, Jordan Schwartzberg, Nicole Ali, Eric Oermann, et al.

    Background: Kidney transplant (KT) candidates often experience hospitalizations, increasing their delirium risk. Hospitalizations and delirium are associated with worse post‐KT outcomes, yet their relationship with pre‐KT outcomes is less clear. Pre‐KT delirium may worsen access to KT due to its negative impact on cognition and ability to maintain overall health.Methods: Using a prospective cohort of 2374 KT candidates evaluated at a single center (2009–2020), we abstracted hospitalizations and associated delirium records after listing via chart review. We evaluated associations between waitlist mortality and likelihood of KT with hospitalizations and hospitalized delirium using competing risk models and tested whether associations differed by gerontologic factors.Results: During a median of 1.8 years after listing, 735 (31.0%) candidates had ≥1 hospitalizations. Candidates with less education, frailty, depressive symptoms, and lower extremity function impairment were more likely to be hospitalized. Hospitalization was associated with higher waitlist mortality (aSHR = 3.65, 95% CI: 2.99–4.45) and a lower likelihood of KT (aSHR = 0.74, 95% CI: 0.66–0.84). Among candidates who were hospitalized, 80 (11%) had ≥1 delirium episodes. Candidates who were older, frail, and impaired in lower extremity function were more likely to have delirium, which was associated with higher waitlist mortality (aSHR = 4.87, 95% CI: 3.42–6.93) and a lower likelihood of KT (aSHR = 0.45, 95% CI: 0.27–0.74). The association between hospitalization and KT differed by candidate age (pinteraction < 0.001), with those aged ≥65 having a 61% lower likelihood of KT.Conclusion: Hospitalization and delirium are associated with worse pre‐KT outcomes and have serious implications on candidates’ access to KT. Providers should work to reduce preventable instances of delirium.


  • Targeted Broader Sharing for Liver Continuous Distribution

    by Michal A. Mankowski, Nicholas L. Wood, Allan B. Massie, Dorry L. Segev, Nikolaos Trichakis, Sommer E. Gentry

    Background. In recent years, changes to US organ allocation have aimed to improve equity and accessibility across regions. The Organ Procurement and Transplantation Network plans to adopt continuous liver distribution, prioritizing candidates based on a weighted composite allocation score (CAS) incorporating proximity, ABO types, medical urgency, and pediatric priority. The Liver Committee has requested research on CAS variations that account for geographical heterogenicity. Methods. We describe a method for designing a geographically heterogeneous CAS with targeted broader sharing (CAS-TBS) to balance the highly variable geographic distributions of liver transplant listings and liver donations. CAS-TBS assigns each donor hospital to either broader sharing or nearby sharing, adjusting donor-candidate distance allocation points accordingly. Results. We found that to reduce geographic disparity in the median Model for End-stage Liver Disease at transplant (MMaT), >75% of livers recovered in regions 2 and 10 should be distributed with broader sharing, whereas 95% of livers recovered in regions 5 and 1 should be distributed with nearby sharing. In a 3-y simulation of liver allocation, CAS-TBS decreased MMaT by 2.1 points in high-MMaT areas such as region 5 while increasing MMaT only by 0.65 points in low-MMaT areas such as region 3. CAS-TBS significantly decreased median transport distance from 202 to 167 nautical miles under acuity circles and decreased waitlist deaths. Conclusions. Our CAS-TBS design methodology could be applied to design geographically heterogeneous allocation scores that reflect transplant community values and priorities within the continuous distribution project of the Organ Procurement and Transplantation Network. In our simulations, the incremental benefit of CAS-TBS over CAS was modest. Export